Monica Gandhi

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Monica Gandhi
    Department of Medicine, University of California, San Francisco 94122, USA
    AIDS 19:1885-96. 2005
  2. ncbi Protease inhibitor levels in hair strongly predict virologic response to treatment
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS 23:471-8. 2009
  3. ncbi Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women
    Monica Gandhi
    Department of Medicine, University of California San Francisco, 405 Irving Street, 2nd Floor, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 50:482-91. 2009
  4. ncbi Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy
    Monica Gandhi
    Departments of Medicine, University of California, San Francisco, 94122, USA
    Clin Infect Dis 52:1267-75. 2011
  5. ncbi Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry
    Yong Huang
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Anal Bioanal Chem 401:1923-33. 2011
  6. ncbi Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry
    Yong Huang
    Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143, USA
    Rapid Commun Mass Spectrom 22:3401-9. 2008
  7. ncbi Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women
    Chenglong Liu
    Department of Medicine, Georgetown University, Washington, D C 20007, USA
    AIDS Patient Care STDS 23:965-71. 2009
  8. ncbi Analysis of pharmacogenetic traits in two distinct South African populations
    Ogechi Ikediobi
    University of California, San Francisco, School of Pharmacy, Department of Clinical Pharmacy, CA 94143, USA
    Hum Genomics 5:265-82. 2011
  9. ncbi Sex differences in pharmacokinetics and pharmacodynamics
    Monica Gandhi
    Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California 94143 1352, USA
    Annu Rev Pharmacol Toxicol 44:499-523. 2004
  10. ncbi Does patient sex affect human immunodeficiency virus levels?
    Monica Gandhi
    Department of Medicine, Infectious Diseases Division, University of California, San Francisco, CA, 94143, USA
    Clin Infect Dis 35:313-22. 2002

Research Grants

  1. Assessing antiretroviral exposure in diverse populations
    Monica Gandhi; Fiscal Year: 2007

Detail Information

Publications21

  1. ncbi Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Monica Gandhi
    Department of Medicine, University of California, San Francisco 94122, USA
    AIDS 19:1885-96. 2005
    ....
  2. ncbi Protease inhibitor levels in hair strongly predict virologic response to treatment
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS 23:471-8. 2009
    ..The currently available methods to assess ARV exposure are limited. Levels of ARVs in hair reflect plasma concentrations over weeks to months, and may provide a novel method for predicting therapeutic responses...
  3. ncbi Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women
    Monica Gandhi
    Department of Medicine, University of California San Francisco, 405 Irving Street, 2nd Floor, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 50:482-91. 2009
    ....
  4. ncbi Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy
    Monica Gandhi
    Departments of Medicine, University of California, San Francisco, 94122, USA
    Clin Infect Dis 52:1267-75. 2011
    ..Hair concentrations of antiretrovirals can integrate adherence and pharmacokinetics into a single assay...
  5. ncbi Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry
    Yong Huang
    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Anal Bioanal Chem 401:1923-33. 2011
    ..We also showed that NVP in human hair can easily be detected in a single short strand of hair. This method will allow us to identify drug non-adherence using even a single strand of hair...
  6. ncbi Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry
    Yong Huang
    Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143, USA
    Rapid Commun Mass Spectrom 22:3401-9. 2008
    ..This developed method allowed for the monitoring of these target medications in the hair samples of HIV-infected women on antiretroviral therapy in an observational study using small amounts of hair...
  7. ncbi Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women
    Chenglong Liu
    Department of Medicine, Georgetown University, Washington, D C 20007, USA
    AIDS Patient Care STDS 23:965-71. 2009
    ..Interventions targeted towards both physicians and patients may enhance communication of CAM use, avoid potential adverse events and drug interactions, and enhance HAART adherence...
  8. ncbi Analysis of pharmacogenetic traits in two distinct South African populations
    Ogechi Ikediobi
    University of California, San Francisco, School of Pharmacy, Department of Clinical Pharmacy, CA 94143, USA
    Hum Genomics 5:265-82. 2011
    ..Characterising the Xhosa and CMA population frequencies of variant alleles important for drug transport and metabolism can help to establish the clinical relevance of pharmacogenetic testing in these populations...
  9. ncbi Sex differences in pharmacokinetics and pharmacodynamics
    Monica Gandhi
    Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California 94143 1352, USA
    Annu Rev Pharmacol Toxicol 44:499-523. 2004
    ....
  10. ncbi Does patient sex affect human immunodeficiency virus levels?
    Monica Gandhi
    Department of Medicine, Infectious Diseases Division, University of California, San Francisco, CA, 94143, USA
    Clin Infect Dis 35:313-22. 2002
    ..This finding is significant, because viral loads are frequently used to guide the initiation and modification of antiretroviral therapy...
  11. ncbi The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation
    Elvin H Geng
    Division of HIV AIDS, San Francisco General Hospital, and Department of Medicine, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Clin Infect Dis 53:1008-14. 2011
    ..Subsequently, the San Francisco General Hospital (SFGH) HIV/AIDS Service performed the SFGH 5164 Initiative to disseminate and implement the findings of ACTG 5164...
  12. ncbi Poverty, unstable housing, and HIV infection among women living in the United States
    Elise D Riley
    University of California at San Francisco, UCSF Box 1372, Epidemiology and Prevention Interventions Center, San Francisco, CA 94143 1372, USA
    Curr HIV/AIDS Rep 4:181-6. 2007
    ..Suggestions for service provision are offered with the understanding that providers may have limited time and expertise to meet the entire array of needs for impoverished women...
  13. ncbi Human herpesvirus 8, Kaposi's sarcoma, and associated conditions
    Monica Gandhi
    Infectious Diseases Division, Department of Medicine, University of California, San Francisco, 405 Irving Street, Second Floor, San Francisco, CA 94122, USA
    Clin Lab Med 22:883-910. 2002
    ..Specific antiviral drug inhibit HHV-8 replication, and can result in responses in certain HHV-8-associated conditions...
  14. ncbi Hair it is: the long and short of monitoring antiretroviral treatment
    Monica Gandhi
    Ann Intern Med 137:696-7. 2002
  15. ncbi Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study
    Michael J Silverberg
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 39:717-24. 2004
    ..The extended use of antiretroviral drugs among human immunodeficiency virus (HIV)-seropositive individuals underscores the need for a comprehensive evaluation of therapy-associated clinical symptoms...
  16. ncbi Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
    Joseph G Feldman
    SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA
    Am J Public Health 96:1060-5. 2006
    ..We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women...
  17. ncbi Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships
    Tracey E Wilson
    Department of Preventive Medicine and Community Health, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    AIDS Educ Prev 19:151-9. 2007
    ..Conclusions: These findings highlight the importance of ongoing support for sexual risk reduction among women with HIV-infection and for strategies that reduce the strength of relationships between ART beliefs and sexual risk behavior...
  18. ncbi Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy
    Elizabeth T Golub
    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland 21205, USA
    Clin Infect Dis 46:305-12. 2008
    ....
  19. ncbi Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
    Chenglong Liu
    J Altern Complement Med 13:1053-6. 2007
  20. ncbi Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection
    Lynda A Szczech
    J Acquir Immune Defic Syndr 48:360-1. 2008
  21. ncbi Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study
    Daniel J Merenstein
    Georgetown University Medical Center, Department of Family Medicine, 417 Kober Cogan Hall, 3800 Reservoir Rd, NW, Washington, DC 20007, USA
    Pediatrics 121:e787-93. 2008
    ..The purpose of this work was to evaluate whether living with children adversely affects adherence to highly active antiretroviral therapy in HIV-infected women...

Research Grants2

  1. Assessing antiretroviral exposure in diverse populations
    Monica Gandhi; Fiscal Year: 2007
    ..abstract_text> ..